Fast-food operators are altering menus to match shifting eating habits among customers who are taking GLP-1 weight-loss medications. Chains say people on those drugs still want fast food, but prefer items that deliver protein, smaller portions and fewer calories.
McDonald's announced plans to introduce more protein-forward and lower-calorie items, including grilled chicken sandwiches, wraps and egg bites. Company leaders framed the moves as part of a broader menu refresh tied to an $8.5 billion investment in restaurant upgrades over the next decade. McDonald's executives said the goal is to retain customers whose preferences are changing, not to win an entirely new customer base.
Shake Shack has introduced the "Good Fit Menu," which lists gluten-free, vegetarian and "GLP-1-friendly choices." Many burger options on that menu are served in lettuce wraps rather than buns to reduce carbohydrates and calories.
Chipotle provides a webpage with menu options it labels helpful for people on a "GLP-1 journey," including a low-calorie chicken bowl built on lettuce and a higher-fiber chicken bowl with rice.
A study published in the Journal of Marketing Research found that households with at least one GLP-1 user cut spending at fast-food restaurants, coffee shops and other eateries by about 8% within the first six months of starting the drugs. That decline in spending has prompted food companies to consider product changes that match new eating patterns.
How restaurants frame the opportunity
What these menu changes look like in practice
- Smaller plates and bowls. Chains are testing bowls and wraps that reduce carbohydrate-heavy components like buns and large rice portions.
- Protein emphasis. Grilled chicken, egg-based items and other higher-protein offerings are being added or promoted.
- Clear labeling. Some chains are marketing specific menu pages or labeled items as low-calorie, high-fiber or GLP-1–friendly to help customers choose items aligned with their diets.
Business trade-offs and expectations
Expect more diversity across menus as chains experiment with combinations of smaller portions, higher-protein ingredients and clearer nutrition labeling. Look for additional product tests and dedicated menu pages that group options for customers tracking calories, protein intake or other diet goals.
Fast-food companies are reshaping menus to meet the needs of customers using GLP-1 drugs by offering smaller portions and protein-focused choices. The approach is about keeping existing diners as their eating patterns change, responding to measurable shifts in household spending after people start these medications.